WALLACE PHARMACEUTICALS PVT LTD

Goa-based Wallace Pharmaceuticals generated a revenue of Rs 31 crore in the biopharma space during FY 20-21, exhibiting a slight growth of 8 per cent as compared to Rs 29 crore worth revenue generated in FY 19-20. The company markets a basket of over 200 products focusing on antibiotics, gastrointestinal, rheumatology, dermatology, gynecology, diabetology, ENT and pediatrics. Wallace Pharma is a part of the Wallace Group which also handles Indi Pharma and Goodwin Biotechnology Inc. The Wallace Group is primarily engaged in the manufacture and marketing of formulation products in India as well as abroad.